El Kenz Hanane, Bergmann Pierre
Service de Biologie Clinique, Laboratoire RIA-Hormonologie, CHU-Brugmann, 1020 Bruxelles, Belgique.
Clin Lab. 2004;50(3-4):171-4.
We evaluated new immunochemiluminometric assays (ICMAs) for insulin and C-peptide (ADVIA Centaur Insulin & C-Peptide-Serum assays). Both ADVIA Centaur assays are two-site sandwich immunoassays using direct chemiluminescent technology. Precision was investigated using serum pools at three levels of the two analytes, measured in duplicate for 10 days. Total Coefficient of Variations (CVs) were 5, 7 and 4% for insulin and 9, 6 and 10% for C-peptide, with intra-assay precisions of 5, 4 and 5% and 5, 3 and 3%, respectively. The minimum detectable concentrations were 0.5 mU/L and < 0.1 microg/L for insulin and for C-peptide, respectively. Day-to-day reproducibility of single measurements was 5.4, 7.1 and 4.3% for pools with an insulin concentration of 0.6 mU/L, 2.0 mU/L and 4.0 mU/L; it was 4.4, 6.6 and 5.3% for pools with a C-peptide concentration of 0.2, 0.3 and 1.0 microg/L. The functional sensitivity did not differ from 3 SD Minimal Detectable Concentration (MDC) (0.5 mU/L for insulin and < 0.1 microg/L for C-peptide). The linearity was good in the range of 0.6-20 mU/L for insulin and 0.3-9 microg/L for C-peptide. The comparison with the RIA used in our laboratory was analyzed by Passing-Bablok and Bland-Altman plots and revealed a proportional bias of approximately 20% (slope: 1.20; CI: 1.14 to 1.26) for C-peptide and a systematic bias of -1.6 mU/L (slope: 0.94; CI: 2.7 to -0.5) for insulin which should not have any clinical consequence in the interpretation of results. Finally, we tested the influence of hemolysis on insulin in serum and plasma and found the same negative effect for both samples when more than 2% of red cells were hemolyzed, and this effect increased with the lag time before freezing. In conclusion, both assays were satisfactorily correlated with the routine RIA test used in our laboratory. The major problem was the sensitivity to hemolysis which is common to all insulin immunometric assays.
我们评估了用于胰岛素和C肽的新型免疫化学发光测定法(ICMAs)(ADVIA Centaur胰岛素和C肽血清测定法)。两种ADVIA Centaur测定法均为采用直接化学发光技术的双位点夹心免疫测定法。使用两种分析物三个水平的血清混合液研究精密度,一式两份测量10天。胰岛素的总变异系数(CVs)分别为5%、7%和4%,C肽的总变异系数分别为9%、6%和10%,批内精密度分别为5%、4%和5%以及5%、3%和3%。胰岛素和C肽的最低检测浓度分别为0.5 mU/L和<0.1 μg/L。胰岛素浓度为0.6 mU/L、2.0 mU/L和4.0 mU/L的混合液单次测量的日间重复性分别为5.4%、7.1%和4.3%;C肽浓度为0.2 μg/L、0.3 μg/L和1.0 μg/L的混合液单次测量的日间重复性分别为4.4%、6.6%和5.3%。功能灵敏度与3倍标准差最低检测浓度(MDC)(胰岛素为0.5 mU/L,C肽为<0.1 μg/L)无差异。胰岛素在0.6 - 20 mU/L范围内、C肽在0.3 - 9 μg/L范围内线性良好。通过Passing - Bablok和Bland - Altman图分析了与我们实验室使用的放射免疫分析(RIA)的比较,结果显示C肽存在约20%的比例偏差(斜率:1.20;置信区间:1.14至1.2),胰岛素存在 - 1.6 mU/L的系统偏差(斜率:0.94;置信区间:2.7至 - 0.5),这在结果解释中不应产生任何临床影响。最后,我们测试了溶血对血清和血浆中胰岛素的影响,发现当超过2%的红细胞溶血时,两种样本均有相同的负面影响,且这种影响随着冷冻前的延迟时间增加。总之,两种测定法与我们实验室使用的常规RIA检测结果相关性良好。主要问题是对溶血敏感,这是所有胰岛素免疫测定法共有的问题。